Proteomics International said Monday that it has signed a deal with Eurobio Scientific for the exclusive distribution of its PromarkerD diabetic kidney disease test in France.

Under the terms of the deal, which will last for five years and is extendable for additional five-year periods, Proteomics International will receive a payment for each PromarkerD test kit sold. Additional terms of the deal were not disclosed.